Roche Diagnostic Ltd.
Roche is a global healthcare company dedicated to innovating in pharmaceuticals, diagnostics, and digital health solutions. Their mission is to improve health outcomes by preventing, diagnosing, and treating diseases, with a focus on creating a healthier future for all. They emphasize innovation driven by science, data, and insights, and are committed to sustainability, social responsibility, and making a positive impact on communities worldwide.
Industries
Nr. of Employees
Very Large (1000+)
Roche Diagnostic Ltd.
F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland
Patents
Products
Pharmaceuticals across oncology, viral, CNS and inflammatory diseases
Therapeutic medicines developed through discovery and clinical development programs targeting major disease areas.
Diagnostic tests and laboratory instruments
In‑vitro diagnostic assays and clinical laboratory instruments intended for disease detection, monitoring and clinical decision support.
Digital health solutions and data platforms
Software platforms and digital tools that integrate with diagnostics and care pathways to support personalised healthcare and data‑driven decisions.
Continuous ocular drug‑delivery system for diabetic macular edema
A continuous intraocular drug‑delivery treatment approach offered as an alternative to frequent intraocular injections for diabetic macular edema.
Pharmaceuticals across oncology, viral, CNS and inflammatory diseases
Therapeutic medicines developed through discovery and clinical development programs targeting major disease areas.
Diagnostic tests and laboratory instruments
In‑vitro diagnostic assays and clinical laboratory instruments intended for disease detection, monitoring and clinical decision support.
Digital health solutions and data platforms
Software platforms and digital tools that integrate with diagnostics and care pathways to support personalised healthcare and data‑driven decisions.
Continuous ocular drug‑delivery system for diabetic macular edema
A continuous intraocular drug‑delivery treatment approach offered as an alternative to frequent intraocular injections for diabetic macular edema.
Services
Investment and active engagement with early‑stage life science companies to accelerate commercialisation and development.
Investment and active engagement with early‑stage life science companies to accelerate commercialisation and development.
Expertise Areas
- Clinical trial management
- Diagnostic development and laboratory instrumentation
- Pharmaceutical R&D and drug discovery
- Digital health and platform development
Key Technologies
- In‑vitro diagnostics
- Diagnostic instrumentation
- Artificial intelligence / machine learning
- Digital health platforms
News & Updates
Roche publishes its First Quarter Results for 2025
Roche continues with good momentum in 2025 with 6% (CER) sales growth in the first quarter. CEO Thomas Schinecker highlighted the milestones achieved.
How we improved outcomes for patients around the world
Roche's efforts in Pharmaceuticals and Diagnostics have led to remarkable achievements in disease prevention, stopping, and curing.
AI and machine learning: revolutionising drug discovery and transforming patient care
Development of new medicines leveraging AI and ML to enhance data analysis and prediction.
Advancing diabetes care: how predictive technology improves daily management
Technological advancements have transformed diabetes management since Hanna Boëthius's diagnosis in 1985.
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for diabetic macular edema
Susvimo offers an innovative treatment alternative for diabetic eye disease.
Roche publishes its First Quarter Results for 2025
Roche continues with good momentum in 2025 with 6% (CER) sales growth in the first quarter. CEO Thomas Schinecker highlighted the milestones achieved.
How we improved outcomes for patients around the world
Roche's efforts in Pharmaceuticals and Diagnostics have led to remarkable achievements in disease prevention, stopping, and curing.
AI and machine learning: revolutionising drug discovery and transforming patient care
Development of new medicines leveraging AI and ML to enhance data analysis and prediction.
Advancing diabetes care: how predictive technology improves daily management
Technological advancements have transformed diabetes management since Hanna Boëthius's diagnosis in 1985.
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for diabetic macular edema
Susvimo offers an innovative treatment alternative for diabetic eye disease.